3 Critical Near-Term Milestones to Watch With Pfizer's Coronavirus Vaccine

Which coronavirus vaccine candidate is the one to closely monitor right now? There's a good case to be made that it's BNT162b2, which was developed by Pfizer (NYSE: PFE) and BioNTech (NASDAQ: BNTX).

A lot of action should happen between now and the end of the year for BNT162b2. Here are three critical near-term milestones to watch with Pfizer's coronavirus vaccine.

Image source: Getty Images.

Continue reading

Source Fool.com